Table 3

Clinical characteristics of investigated group divided by sex
Compared groups and clinical data Females Males Statistical significance p
n = 40 n = 25
Age (years) 57.9 ± 11.0 52.6 ± 12.3 NS
Hypertension 34 (85.0%) 20 (80.0%) NS
Ischemic heart disease 9 (22.5%) 11 (44.0%) NS
Myocardial infarct 2 (5.0%) 6 (24.0%) p < 0.05
Cardiac failure 18 (45.0%) 7 (28.0%) p < 0.05
IFG/IGT 21 (52.5%) 17 (68.0%) NS
CKD 13 (32.5%) 2 (8.0%) p < 0.05
Stroke 2 (5.0%) 1 (4.0%) NS
Cerebral arteries failure 0 3 (12.0%) p = 0.053
Hyperuricemia 17 (42.5%) 14 (56.0%) NS
Dyslipidemia 37 (92.5%) 24 (96.0%) NS
Tobacco smoking 2 (5.0%) 3 (12.0%) NS
ACEI 31 (77.5%) 15 (60.0%) NS
ARB 13 (32.5%) 4 (16.0%) NS
Diuretics 27 (67.5%) 10 (40.0%) p < 0.05
CCA 12 (30.0%) 7 (28.0%) NS
BB 17 (42.5%) 8 (32.0%) NS
Spironolactone 14 (35.0%) 4 (16.0%) NS
ARA 1 (2.5%) 6 (24.0%) p = 0.01
ASA 10 (25.0%) 7 (28.0%) NS
Hypolipemic treatmenta 20 (50.0%) 15 (60.0%) NS

a – statins and/or fibrates.

Stępień et al.

Stępień et al. Lipids in Health and Disease 2014 13:29   doi:10.1186/1476-511X-13-29

Open Data